Page 120 - Bioterrorism
P. 120

119



               BirMex - http://www.birmex.gob.mx/

               http://translate.google.com/translate?hl=en&sl=es&u=http://www.birmex.gob.mx/&ei=LPjzSb-
               XFOCblQeZv7XRDA&sa=X&oi=translate&resnum=1&ct=result&prev=/search%3Fq%3DBirme
               x%26hl%3Den%26sa%3DG

               Biological Laboratories Reagents and Mexico, SA de CV (Birmex) is a company owned by the
               Federal Government of Mexico that develops, produces and sells imported vaccines, sera and
               heterologous clinical diagnostic products.

               To meet the demand of the Mexican market, Birmex also sells vaccines, immunoglobulins and
               diagnostic products manufactured by other companies.

               Faced with the challenges of the future, Birmex is developing new vaccines  with modern
               technology to complement its service to its customers.


               Bruce Japsen | Tribune staff reporter
                   11:43 AM CDT, May 7, 2009

               Baxter International Inc. confirmed today that it has received a strain of the swine flu virus and is
               "taking all of the appropriate steps necessary to prepare for a large scale vaccine production," the
               company said in a statement to the Tribune.

               The Obama administration has yet to decide whether any large scale manufacturing of dosages is
               even necessary or whether any stockpile contracts would even be awarded. But Deerfield-based
               Baxter and several other vaccine makers this week are receiving strains of the virus to begin
               testing.

               "Baxter can confirm that we are working on a vaccine and we have received a strain for testing
               and evaluation," said Baxter spokesman Christopher Bona. "We need to evaluate the strain."

               The task of developing a vaccine begins for Baxter after the strain arrives at its Vienna research
               and development labs. The virus arrived via flight from Atlanta, where epidemiologists from the
               U.S. Centers for Disease Control and Prevention have been tracking the spread of the virus.
               Baxter would not say when its researchers obtained the virus strains.

               "It could take three to four weeks to evaluate the growth characteristics of the strain in the vero
               cell culture," Bona said in an interview earlier this week.


               Ill-based Baxter working on swine flu vaccine
               « on: April 25, 2009, 11:39:12 PM »
               ________________________________________
               Ill-based Baxter working on swine flu vaccine

               http://www.forbes.com/feeds/ap/2009/04/25/ap6338850.html

               Specialty drug maker Baxter International Inc. will work with the World Health Organization to
               develop a vaccine that could stem an outbreak of a deadly swine flu strain in Mexico.

               Baxter spokesman Christopher Bona said Saturday that the Deerfield, Ill.-based company has
               asked the WHO for a sample of the flu strain.
   115   116   117   118   119   120   121   122   123   124   125